Health System Cardiac RPM ROI: 2026 Guide for Finance Teams

Key Takeaways For Cardiac RPM ROI

• Cardiac RPM ROI depends on adherence capture, CPT documentation accuracy, and staffing design. Device choice matters less than execution.
• The core formula is ROI = (Reimbursement + Avoided Utilization + Quality Incentives) − Program Costs. Each variable needs program-specific data.
• Per-patient costs average around $330, with variation driven by staffing ratios, platform fees, device amortization, and overhead.
• CIED and HF/HTN programs use different billing cycles and code families, so each requires its own financial model.
• Rhythm360 unifies CIED and RPM data, triages alerts with AI, and captures CPT documentation automatically. Programs using it have achieved up to 80% faster alert response and up to 300% revenue capture gains.

See How Rhythm360 Models Your Program's ROI

Is Remote Patient Monitoring Profitable for Health Systems?

Profitability depends on adherence capture, CPT documentation accuracy, and staffing design. The device itself is a prerequisite, not a differentiator. A peer-reviewed hypertension RPM study found an average program cost of approximately $330 per patient and an average ROI of 22.2% at 55% patient compliance. Across the study's programs, ROI ranged from negative at the high-cost end to over 90% at the low-cost end. That nearly 100-percentage-point swing was driven entirely by operational assumptions.

The same CPT codes, the same condition, and the same device can produce very different financial outcomes. Program design and day-to-day execution create those differences. Profitability is a property of a specific program's operational execution. That reality means finance teams need a model built from their own numbers, not generic multipliers.

The RPM ROI Model: A Formula Health System Finance Teams Can Populate

The foundational ROI formula for a cardiac RPM program is:

ROI = (Reimbursement + Avoided Utilization + Quality Incentives) − Program Costs

The four variables below are the only inputs a finance team needs to populate. Each one requires a cited source and a program-specific assumption, and together they determine whether the model survives a budget committee review. The formula is designed for your panel size, payer mix, and staffing costs, not as a one-size headline number.

1. Reimbursement: Direct Medicare billing revenue from CPT codes covering device setup, data transmission, and clinical management time. The 2026 CMS national reference rates for core RPM codes are approximately $21.71 for CPT 99453 (one-time setup), $52.11 for CPT 99454 (device supply, 16–30 days), $51.77 for CPT 99457 (first 20 minutes of management), and $41.42 for CPT 99458 (each additional 20 minutes). CIED-specific codes operate on different cycles and are addressed in the segmentation section below.
2. Avoided Utilization: The cost of hospitalizations, readmissions, and emergency department visits that monitoring prevents. Heart failure RPM is estimated to prevent approximately $1,300 in readmission costs per patient per year based on a 20% baseline readmission rate, a 50% reduction from monitoring, and a $13,000 average readmission cost. For a 500-patient HF panel, annual readmission avoidance can exceed $650,000 and often surpasses direct billing revenue.
3. Quality Incentives: MIPS performance scores, value-based contract bonuses, and ACO shared savings attributable to RPM-driven outcome improvements. RPM supports MIPS quality measures through continuous monitoring and care coordination, potentially improving scores and increasing Medicare incentives. The dollar value depends on the program's current quality baseline and contract structure.
4. Program Costs: The sum of device costs, platform fees, staffing, patient onboarding, and billing administration. The cost anatomy appears in the next section.

Generic RPM ROI claims such as "4–7x return" do not account for payer mix, patient compliance, staffing model, or condition distribution. Budget committees expect those variables to be stated explicitly.

Get a Program-Specific Cost Breakdown

Remote Patient Monitoring Cost Per Patient: Required Cost Inputs

A peer-reviewed hypertension RPM study anchors per-patient program cost at approximately $330, with a range from $208 to $452 depending on operational efficiency. That same study highlights four cost buckets that every model must include.

1. Staffing: The largest cost component, representing 40–55% of total program cost. A care manager at a 1:85 patient ratio with AI triage costs approximately $73 per patient per month in loaded salary; the same role at a 1:35 ratio without AI triage costs approximately $179 per patient per month, a 2.5x difference in staffing economics. The staffing ratio is the single variable most likely to break a projected ROI.
2. Technology Platform: Platform and software fees typically run $10–$30 per patient per month, representing 10–25% of program cost.
3. Devices and Sensors: Device costs run $50–$100 per unit amortized over 18–24 months, plus approximately 8% annual replacement, representing 10–15% of program cost.
4. Overhead: Billing administration, quality reporting, and patient support add approximately 15% of gross revenue.

Two variables most often cause projected ROI to miss actual results. The first is adherence thresholds. CPT 99454 requires 16 days of automatically transmitted data in a 30-day period; a patient who transmits only 12 days generates zero device-supply revenue for that month, while the practice absorbs 100% of that month's device, platform, and staffing costs. The 2026 addition of CPT 99445, which covers 2–15 days of data, partially mitigates this at lower effective reimbursement for the management component.

The second variable is staffing ratios. As shown above, the difference between an AI-assisted and a manual triage model is the difference between a program that scales and one that stalls at small panel sizes.

CIED Remote Monitoring vs. HF/HTN RPM ROI: Segmenting Cardiac Economics

CIED remote monitoring and HF/HTN physiological monitoring operate on different billing cycles, different code families, and different cost drivers. Treating them as a single financial model produces unreliable projections, so the two must be segmented.

CIED Remote Monitoring Economics (90-Day Cycle)

Pacemaker and ICD remote monitoring is billed on 90-day cycles. CPT 93294 covers professional pacemaker interrogation. CPT 93295 covers professional ICD interrogation. CPT 93296 is the technical component code for both pacemakers and ICDs. Each of these codes can be split into professional (modifier -26) and technical (modifier -TC) components. This matters when the interpreting physician and the facility billing the technical work are separate entities.

CMS reimburses $19.41 for CPT 93296, based on an assumption that the work takes 28 minutes, when in practice it takes closer to 84 minutes, which creates a structural reimbursement gap and makes staffing efficiency the primary ROI lever for CIED programs. Published economic evaluations generally find CIED remote monitoring cost-effective, with ROI driven more by avoided hospital utilization and operational efficiency than by per-transmission revenue. A 2026 study at Helsinki University Hospital found exclusive remote monitoring of pacemaker patients was €38.65–€78.31 per patient per year less expensive than traditional monitoring, with cost savings contingent on whether remote monitoring substituted for, rather than supplemented, in-office visits.

HF/HTN Physiological Monitoring Economics (30-Day Cycle)

Physiological monitoring for heart failure and hypertension operates on 30-day cycles with device-specific codes. CPT 93297 covers implantable cardiovascular physiologic monitors such as CardioMEMS pulmonary artery pressure sensors. CPT 93298 covers subcutaneous cardiac rhythm monitors and implantable loop recorders (ILR/ICM). These are device-specific codes, not a professional and technical pair. Code 93297 applies to physiologic monitors, and 93298 applies to loop recorders. Each is billable once per 30 days and can be billed global, with modifier -26 (professional), or with modifier -TC (technical).

CardioMEMS device-based remote monitoring for chronic heart failure costs approximately $71,462 per quality-adjusted life year, generally cost-effective but not cost-saving at the device level. The financial case for HF physiological monitoring therefore rests more heavily on avoided utilization than on direct reimbursement.

Device-type mismatch and unbilled technical components are the most common sources of cardiac RPM revenue leakage. Applying 93297 to a loop recorder, or failing to bill the -TC component when the facility is entitled to it, produces claim denials and leaves revenue on the table.

For clinical implementation depth on these program types, see the Cardiology Remote Monitoring: Practice Implementation Guide and How to Monitor Heart Failure Remotely: Cardiology Guide.

What 2026 Medicare and Telehealth Changes Mean for RPM ROI

Reimbursement uncertainty is a first-class variable in any 2026 cardiac RPM ROI model. It belongs in the stress-test section of a CFO presentation. Three 2026 policy developments drive that uncertainty, and each one changes a different input in the model.

On July 14, 2026, CMS issued the CY 2027 Medicare Physician Fee Schedule Proposed Rule, which would, if finalized, restrict billable RPM and RTM services to clinical staff who are direct employees of the billing practitioner's practice, effectively prohibiting the outsourced monitoring model used by many third-party vendors, and would require a separately billable face-to-face initiating visit before monitoring services begin.

The proposed rule would also revise practice expense valuations for certain device supply and setup codes and eliminate practice expense inputs for treatment management codes, resulting in a meaningful reimbursement reduction for some commonly billed remote monitoring codes. CMS is also seeking comment on consolidating the existing 17 RPM and RTM CPT codes into four new HCPCS G-codes, though no specific valuations for those codes have been proposed.

The Consolidated Appropriations Act of 2026 extended key Medicare telehealth flexibilities through December 31, 2027, but that extension does not raise RPM payment rates. It preserves telehealth access while leaving RPM reimbursement subject to separate structural scrutiny.

The practical implication for ROI modeling is to run two scenarios: a base case using current 2026 reimbursement rates, and a downside case that models the impact of the proposed direct-employment requirement and potential code consolidation. Under the proposed rule, practices could still purchase software platforms and technical tools from outside vendors. Clinical monitoring work, however, would need to be performed by the practice's own employed clinical staff. That distinction affects staffing cost assumptions materially. Comments on the proposed rule were due September 14, 2026. If adopted, the final rule would take effect January 1, 2027, making 2026 a transition year for planning.

The Operational Levers That Make Or Break Cardiac RPM ROI

Three operational levers determine whether a projected cardiac RPM ROI materializes: adherence capture, CPT documentation accuracy, and staffing design. Each maps directly to a line item in the ROI formula.

Adherence Capture

Published RPM adherence studies report 30-day retention rates ranging from 60% to over 90%, depending on patient population, device design, and care-team engagement protocols. A program operating at 60% adherence leaves a substantial portion of potential device-supply billing uncaptured every month. Automated patient outreach, device connectivity monitoring, and proactive re-engagement workflows move adherence toward the high end of that range.

CPT Documentation Accuracy

CPT 99454 may be billed only when an FDA-defined device automatically transmits data on at least 16 days within a 30-day period; if a patient transmits only 15 days, the practice absorbs 100% of that month's device, connectivity, platform, and staffing costs with no reimbursement. For CIED programs, device-type mismatch is the most common source of claim denials. Automated CPT code capture that tracks device-specific billing requirements, 90-day cycles for pacemakers and ICDs, and 30-day cycles for physiologic monitors and loop recorders functions as a revenue protection mechanism.

University of Chicago Medicine, after implementing Rhythm360, reported improved billing and accountability for patients, with clinicians able to review more transmissions daily and identify more abnormalities. UCM managed over 73,000 reports annually through the platform in 2025. These results show how platform-level documentation infrastructure affects billing outcomes at scale.

Staffing Design And Alert Triage

Clinical workflow friction was the single most prevalent RPM deployment bottleneck in a 2026 scoping review, appearing in 27.1% of 701 charted implementation records, more than any hardware or technology issue. Alert triage and EHR integration are the two workflow variables with the largest effect on staff review time and therefore cost per patient. Research published in Europace found that in some CIED remote monitoring programs, only 7% of alerts were judged to be clinically meaningful, which means staff spend most review time on transmissions that require no action. AI-powered alert triage that filters non-actionable noise before it reaches clinical staff directly reduces cost per patient and helps prevent the burnout that drives staff turnover.

That alert triage lever is the one Rhythm360 was built to pull. Rhythm360 by RhythmScience is a vendor-neutral, HIPAA-compliant platform that unifies CIED and RPM data into a single source of truth. It integrates bi-directionally with Epic, Cerner, Athenahealth, eClinicalWorks, Greenway Health, and others via HL7. It also provides AI-powered alert triage and automated CPT code capture and documentation. An optional 24/7/365 oversight layer staffed by certified cardiac technicians is available for programs that require it. Practices implementing Rhythm360 have achieved up to an 80% reduction in critical alert response times and up to a 300% increase in revenue capture.

Stress-Test Your Cardiac RPM Business Case

How to Present the Cardiac RPM ROI Model to Your CFO

A transparent model with stated assumptions is more defensible than a single ROI number. The checklist below covers the minimum requirements for a budget-committee-ready cardiac RPM business case.

1. State your assumptions explicitly. Panel size, payer mix (Medicare FFS vs. Medicare Advantage vs. commercial), patient adherence rate, staffing ratio, and platform cost per patient must all be named.
2. Cite your sources. Every reimbursement rate should reference the CMS fee schedule. Every avoided-utilization figure should reference a peer-reviewed study. Every staffing cost should reference your own HR data or a published benchmark.
3. Show the break-even range. Most RPM programs break even in 2–3 months at modest panel sizes with existing staff and an off-the-shelf platform. Larger programs with dedicated staff may take 3–4 months but generate proportionally larger ongoing margins. Present the range, not a single point estimate.
4. Name the variables that could break the model. Adherence falling below the 16-day CPT 99454 threshold, payer mix shifting toward plans with restricted RPM coverage, and the CY 2027 proposed rule's direct-employment requirement are the three variables most likely to cause actual results to diverge from projections. A model that names these risks is more credible.
5. Run a reimbursement stress test. Model the downside scenario in which the CY 2027 proposed rule is finalized as written. Show what the program looks like if treatment management code reimbursement is reduced and outsourced monitoring time is no longer billable. If the program is still viable under that scenario, the business case is defensible.

Conclusion: Building A Defensible Cardiac RPM Business Case

Cardiac RPM ROI is determined by workflow, adherence, and compliance. The device is a prerequisite; the operational infrastructure is what separates a program that delivers projected returns from one that does not. Programs that actively manage adherence, maintain accurate CPT documentation, and design staffing to scale without proportional cost increases are the ones that sustain positive margins.

The evaluation framework for any cardiac RPM investment should be a transparent, source-cited model populated with the program's own assumptions, including panel size, payer mix, staffing ratio, and adherence rate. That model should be stress-tested against the reimbursement uncertainty that CMS's CY 2027 proposed rule has introduced as a real planning variable. A model built that way is defensible to a budget committee.

Stress-Test Your Cardiac RPM Model With Rhythm360

Read Next

• Cost Effectiveness & ROI of Heart Failure Remote Monitoring
• Remote Patient Monitoring Benefits for Cardiology in 2026
• Cardiac Remote Monitoring: 2026 Guide to Devices & Costs
• Maximize 2026 Remote Heart Rhythm Monitoring Reimbursement
• ROI of Revenue Cycle Management for Cardiology Practices